Abnormal 3,4-dihydroxyphenylalanine (dopa) concentrations in plasma and urine of patients with cystic fibrosis

European Journal of Clinical Investigation
M H SchöniR Kraemer

Abstract

Plasma and urine concentrations of the free amino acid 3,4-dihydroxyphenylalanine (dopa) were determined in a blind study in 16 children and adolescents with cystic fibrosis (CF), eight heterozygote parents of these children and in 11 healthy subjects who served as controls. To exclude any drug interference with catecholamine metabolism and to evaluate a tentative basic metabolic alteration in cystic fibrosis, the same determinations were done in 11 newly diagnosed infants (age 1-84 months). Free plasma dopa was significantly (P less than 0.01) elevated in CF (27.0 +/- 6.1 nmol l-1 vs. 19.1 +/- 5.0 nmol l-1 in the controls); heterozygotes had the lowest concentration: 11.5 +/- 5.8 nmol l (P less than 0.01 compared with normals). Increased plasma dopa concentrations were measured in the newly diagnosed infants (35.4 +/- 16.9 nmol l-1). Renal dopa clearance was the same in cystic fibrosis (9.26 +/- 5.71 ml min-1 1.73 m-2) and controls (10.87 +/- 2.46 ml min-1 1.73 m-2). A concomitant elevation of metabolic products as dopamine and noradrenaline in plasma and urine was noticed. These data are consistent with a dopa abnormality in this genetic disease.

References

Mar 1, 1979·Clinica Chimica Acta; International Journal of Clinical Chemistry·C R LakeI J Kopin
Jan 1, 1985·Pediatric Research·M H SchöniR Kraemer
Mar 1, 1971·Clinica Chimica Acta; International Journal of Clinical Chemistry·K Türler, H Käser
Sep 1, 1972·Biochemical Pharmacology·M Goodall, H Alton
Apr 1, 1974·Journal of Pharmaceutical Sciences·J RosazzaC J Sih
Nov 1, 1970·Archives of Biochemistry and Biophysics·J G ChristensonS Udenfriend
Jun 26, 1980·The New England Journal of Medicine·P B DavisM Kaliner
Jun 1, 1983·The Journal of Clinical Investigation·P B DavisC F Doershuk
Jan 1, 1984·Clinical Neuropharmacology·J G Nutt, J H Fellman
May 1, 1984·The Journal of Pediatrics·M H SchöniE Rossi
Aug 1, 1963·The New England Journal of Medicine·W VON STUDNITZA SJOERDSMA
Jan 1, 1964·Scandinavian Journal of Clinical and Laboratory Investigation·L R GJESSING
Jan 1, 1974·Pediatric Radiology·A R Chrispin, A P Norman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.